MENU
+Compare
ATHA
Stock ticker: NASDAQ
AS OF
Jun 6 closing price
Price
$0.36
Change
+$0.02 (+5.88%)
Capitalization
14.06M

ATHA Athira Pharma Forecast, Technical & Fundamental Analysis

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more

ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATHA with price predictions
Jun 06, 2025

ATHA in upward trend: 10-day moving average moved above 50-day moving average on May 30, 2025

The 10-day moving average for ATHA crossed bullishly above the 50-day moving average on May 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on ATHA as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ATHA moved above its 50-day moving average on May 27, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATHA advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 161 cases where ATHA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

ATHA broke above its upper Bollinger Band on June 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.377) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (59.923). ATHA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.234). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (260.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATHA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATHA is expected to report earnings to fall 4.35% to -21 cents per share on August 18

Athira Pharma ATHA Stock Earnings Reports
Q2'25
Est.
$-0.22
Q1'25
Missed
by $0.05
Q4'24
Est.
$-0.38
Q3'24
Missed
by $0.05
Q2'24
Beat
by $0.04
The last earnings report on May 09 showed earnings per share of -23 cents, missing the estimate of -18 cents. With 413.44K shares outstanding, the current market capitalization sits at 14.06M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADN2.900.10
+3.57%
Advent Technologies Holdings Inc.
PDM7.620.20
+2.70%
Piedmont Office Realty Trust
WD68.330.95
+1.41%
Walker & Dunlop
CHKP233.472.36
+1.02%
Check Point Software Technologies Ltd
RCKY23.290.07
+0.30%
Rocky Brands

ATHA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with OGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+5.51%
OGEN - ATHA
38%
Loosely correlated
+21.25%
ALNY - ATHA
35%
Loosely correlated
-2.33%
PCVX - ATHA
33%
Poorly correlated
+6.29%
MNKD - ATHA
32%
Poorly correlated
+1.86%
SNGX - ATHA
31%
Poorly correlated
+4.89%
More